Your browser doesn't support javascript.
loading
The path to eradication of rubella.
Reef, Susan E; Icenogle, Joseph P; Plotkin, Stanley A.
Affiliation
  • Reef SE; Atlanta, GA 30345, USA. Electronic address: susanreef4@gmail.com.
  • Icenogle JP; 575 Pharr RD NE, P.O. Box 550081, Atlanta, GA 30355, USA. Electronic address: Jnmadice2@gmail.com.
  • Plotkin SA; University of Pennsylvania, Vaxconsult, 4650 Wismer Rd., Doylestown, PA 18902, USA. Electronic address: Stanley.plotkin@vaxconsult.com.
Vaccine ; 41(50): 7525-7531, 2023 Dec 07.
Article de En | MEDLINE | ID: mdl-37973510
ABSTRACT
Since 1969, rubella and its harmful effect on fetuses infected in utero can be prevented by rubella vaccine, usually given in combination with measles vaccine. The rubella vaccine is highly protective both in children and in adults including women intending to become pregnant. Owing to the use of combined measles and rubella vaccines, congenital rubella infection has been eliminated from the Western Hemisphere and nearly all of Europe. Such combined vaccination is now being applied throughout the world, posing the possibility of eventual rubella eradication. The existence of viruses of animals related to rubella does not appear to be a barrier to eradication of the human virus. However, persistent rubella virus in infants infected in utero and of immunosuppressed patients with granulomas may pose a problem for eradication. Nevertheless, this review posits that eradication of rubella is now feasible if routine vaccination of infants and surveillance for chronic infection are correctly applied.
Sujet(s)

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Rubéole / Rougeole Limites: Adult / Child / Female / Humans / Infant / Pregnancy Langue: En Journal: Vaccine Année: 2023 Type de document: Article

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Rubéole / Rougeole Limites: Adult / Child / Female / Humans / Infant / Pregnancy Langue: En Journal: Vaccine Année: 2023 Type de document: Article
...